Zobrazeno 1 - 10
of 138
pro vyhledávání: ''
Publikováno v:
Clinical Rheumatology. 40:3615-3626
To identify the predictive biomarkers for achieving remission with abatacept in patients with seropositive rheumatoid arthritis (RA).We enrolled patients with RA who were treated with abatacept. We compared the baseline laboratory results and longitu
Autor:
Ratanavadee Nanagara, Ajanee Mahakkanukrauh, Itthiphat Arunsurat, Siraphop Suwannaroj, Chingching Foocharoen
Publikováno v:
Clinical Rheumatology. 40:205-211
Standard regimens for scleroderma interstitial lung diseases (SSc-ILDs) are pulse intravenous (IV) and oral daily cyclophosphamide (CYC). However, IV CYC has limited access to diffuse cutaneous SSc, and oral daily CYC is associated with febrile neutr
Autor:
Toshihiro Nanki, Soichi Yamada, K. Shikano, Makoto Kaburaki, Shinichi Kawai, Mai Kawazoe, Zento Yamada, Sei Muraoka, Hiroshi Sato, Kaichi Kaneko, Shotaro Masuoka, Satoshi Mizutani
Publikováno v:
Clinical Rheumatology. 38:1571-1578
To assess the renal and non-renal efficacy of mycophenolate mofetil (MMF) in Japanese patients with systemic lupus erythematosus (SLE). We conducted a retrospective study to assess the renal and non-renal efficacies of MMF in Japanese patients with s
Autor:
Kimito Kawahata, Harunobu Iida, Tomofumi Kiyokawa, Hisae Fujimoto, Hidehiro Yamada, Hironari Hanaoka, Yoshioki Yamasaki, Yukiko Takakuwa
Publikováno v:
Clinical Rheumatology. 38:1217-1223
Administration of four once-weekly doses of 375 mg/m2 rituximab (RTX) is commonly used as remission induction therapy for ANCA-associated vasculitis (AAV). Low-dose RTX has been recently shown to produce closely similar results to conventional treatm
Autor:
Xiuyan Yang, Zhiyi Zhang, Bo Liu, Guochun Wang, Xiangyuan Liu, Ronghua Xie, Danyi Xu, Yunshan Zhou, Yi Liu, Yongfu Wang, Zhanguo Li, Xin Lu, Yan An, Zhuoli Zhang, Hanshi Xu, Xiaoxia Zuo, Yu Wang, Yang Li, Yi Zhao, Lingyun Sun, Yisha Li, Feng Yu, Weiguo Xiao, Jing Zhang, Zhong-qiang Yao, Jianping Guo, Ping Zhu, Hui Shen, Yingnan Li, Yuan An, Ming-Hui Zhao, Xiaoli Deng, Yifang Mei, Hong Wang, Mei Wang, Jin Lin, Liqi Bi
Publikováno v:
Clinical Rheumatology. 38:1047-1054
The standard strategy for treating lupus nephritis comprises glucocorticoids together with either intravenous cyclophosphamide or oral mycophenolate mofetil, but the low remission rate is still a challenge in practice. This study was aimed to seek hi
Autor:
Alejandro Balsa, Victoria Navarro-Compán, María Ángeles González, Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez, Laura Nuño, Dora Pascual-Salcedo, Pilar Nozal, Irene Monjo, Ana Martínez-Feito
Publikováno v:
Clinical Rheumatology. 38:949-954
To investigate the effect of concomitant conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) with adalimumab or infliximab on maintaining serum drug and clinical outcomes after the first year of treatment in patients with rheumat
Publikováno v:
Clinical Rheumatology. 38:585-590
To evaluate the efficacy and tolerability of mycophenolate mofetil (MMF) with or without calcineurin inhibitors (CNIs) in patients with inflammatory myopathy taking prednisolone, but refractory to conventional immunosuppressive therapy. The records o
Autor:
Ana Zekovic, Ivana Tadić, Nada Vujasinovic Stupar, Slavica Pavlov-Dolijanovic, Predrag Ostojic, Vladimir Zugic, Ivan Jeremic, Tatjana Zivanovic Radnic
Publikováno v:
Clinical Rheumatology
The study aims to analyze the effects of induction treatment with cyclophosphamide (CYC) pulse therapy followed by maintenance treatment with other mild immunosuppressive agents on lung function in scleroderma (SSc) patients. Thirty patients with SSc
Autor:
Yanying Liu, Yingni Li, Wenjie Bian, Jiali Chen, Yuxin Zhang, Wen Zhang, Da Chen, Jiangnan Fu, Xing Sun, Zhanguo Li, Xiaozhen Zhao
Publikováno v:
Clinical rheumatology. 39(2)
To evaluate the therapeutic efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease (IgG4-RD).We conducted a retrospective single-center study in 17 IgG4-RD patients admitted to Peking University People's Hospit
Publikováno v:
Clinical Rheumatology. 37:2633-2641
This study designed to identify the therapeutic efficacy of niclosamide (NCL) in Iraqi patients suffering from active rheumatoid arthritis (RA) who were using etanercept (ETN) for more than 3 months and still had high or moderate active RA. One hundr